A major focus of our lab is engineering innovation for analysis of complex biological systems -- as is required to address questions important to both fundamental biological systems and applied clinical research. We employ a combination of approaches drawn from chemical engineering, mechanical engineering, and electrical engineering with strong foundations in biology, materials science, and analytical chemistry. In essence, we strive to advance the "mathematization" of biology & medicine.
We are part of the UC Berkeley Department of Bioengineering and the UC Berkeley/UCSF Graduate Group in Bioengineering. Our research includes design and development of instrumentation that exploits scale-dependent physics and chemistry. Our work accelerates development of bioanalytical methods, streamlines sample preparation strategies, improves biomarker validation studies, and advances clinical diagnostics.
Affiliations: qb3: The California Institute of Quantitative Biosciences, The Berkeley Stem Cell Center, The Berkeley Center for Emerging and Neglected Diseases, The NSF Center of Integrated Nanomechanical Systems (COINS), and The Lawrence Berkeley National Laboratory.
The Herr Lab acknowledges the generous support of the W.M. Keck Foundation, the Alfred P. Sloan Foundation, the UC Discovery Program, Eli Lilly & Company, Bio-Rad Laboratories, NSF COINS, the Hellman Family, QB3 & the Rogers Family Foundation, DARPA, the NAE/Keck Futures Initiative, the Siebel Stem Cell Institute, the Siebel Scholars Program, Novartis, the US Department of Defense, the Blum Center for Developing Economies, the National Science Foundation (NSF, CBET), the National Institutes of Health (NIH) Office of the Director, the UC Cancer Research Coordinating Committee, & the UC Berkeley Bakar Fellows program.